Phathom Pharmaceuticals, Inc. financial statements, including revenue, expenses, and profit
The total revenue of PHAT for the last quarter is 29.66 M USD, and it's 81.41% higher compared to the previous quarter. The net income of Q4 24 is -74.45 M USD.